Difficult to be sure about the lack of support. We have approval for bugoil in the USA but no distributor (ALS pulled out very strangely 2 days before notification). The EU approval is not due until 2013 according to the last update. The company has been at pains to point out that bugoil is not to be a major focus at this stage. It is emphasising the route to profitability lies in the increasing sales of our other products (mainly Inca). Year end is approaching fast and I would hope that a trading update can tell us if we are on track. We have a new management team (both the CFO and CEO have departed, in addition to a new Chairman). They need time to sort it out. Hopefully there is enough cash to do so.
Have been a holder for over 4 years. Will continue to hold. I have been encouraged by the recent turns of events, although still wary as there has been much promised here that has not come to fruition. This, it must be said, is not the fault of the current BOD. I am optimistic that the new regime will turn this around.
Good research - although the Hardman research is from last May. I assume you are still interested in PIM despite some of your cautious sentiment on this BB? The research shows there are several potential game changers in there (Alathea for example) and points to break even in 2013.
Datafeed and UK data supplied by NBTrader and Digital Look.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.